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Summary The concentrations of retinol and beta carotene were measured in serum samples taken from 113
women with cervical cancer, 32 with invasive and 81 with pre-invasive disease, and compared with those from
226 age-matched control women. There was little difference in serum retinol levels between women with
cancer of the cervix, at any stage, and the control women, after adjusting for potential confounding factors.
Serum beta carotene concentrations were likewise similar in women with invasive disease and the controls.
However mean beta carotene levels were significantly reduced in women with pre-invasive disease compared
to the controls (221.3 cf. 291.6,ugl-1, P<0.05). This reduction was more evident amongst women with a
diagnosis of carcinoma-in-situ (mean 213. lugI1-) than amongst those with severe dysplasia (mean
228.7 jig -1). There is a negative trend between beta carotene and risk of pre-invasive disease which is of
borderline significance. These data have also been used to investigate the effects of smoking and oral
contraceptive usage on the serum levels of retinol and beta carotene. Both habits tend to increase retinol and
decrease beta carotene concentrations.
The hypothesis that the aetiology of epithelial
cancers might be related to a relative deficiency of
dietary vitamin A has created considerable interest
in recent years (Peto et al., 1981; Bollag, 1979). The
association, if proven to be causal, could lead to a
cheap and practical strategy for the prevention of
many forms of cancer. Initial epidemiological
investigations, based either on dietary comparisons
of patients with cancer and controls (Bjelke, 1975;
Mettlin & Graham, 1979; Mettlin et al., 1979;
Shekelle et al., 1981) or on examining serum retinol
levels in relation to subsequent onset of cancer
(Wald et al., 1980; Kark et al., 1981) were in
general supportive of the hypothesis. However,
most studies relying on dietary comparisons are
retrospective in design and open to error in the
accuracy of recall while even positive results do not
distinguish between a vitamin A effect and an effect
due to some other dietary component associated
with vitamin A. Subsequent serum investigations
(Haines et al., 1982; Stahelin et al., 1982; Peleg et
al., 1984; Willet et al., 1984a,b; Nomura et al.,
1985; Salonen et al., 1985) have produced some
positive and some negative results. To help clarify
the position further studies are needed in which
specific cancer sites are examined and biochemical
measures are taken of both serum retinol (the
major form of preformed vitamin A) and serum
f-carotene (the major precursor form of vitamin A).
Sites where squamous cell cancers predominate
merit particular attention. Animal experiments and
in vitro culture work have shown that one of the
results of vitamin A deficiency is alteration of
normal differentiation of cells, giving rise to
squamous cell metaplasia (Bollag, 1979). This is
consistent with the recent finding that the apparent
protective effect of dietary vitamin A against cancer
of the lung is practically limited to the squamous
cell type (Kvale et al., 1983). As the great majority
of cervical cancers are squamous cell in origin
(Raphael & Waterman, 1951) and are thought to be
preceded by squamous metaplasia (Johnson, 1969),
the cervix would seem to be a promising site in
which to investigate the role of vitamin A. Studies
in Italy (La Vecchia et al., 1984), Japan (Hirayama,
1979), and the USA (Marshall et al., 1983; Romney
et al., 1981) have all shown a protective effect for
cervical cancer associated with consumption of
vitamin A containing foods, particularly those with
a high #-carotene content. Four studies have
measured biochemical variables. One found a
deficiency of retinol and retinoic acid binding
proteins in cervical biopsy material from cancer
cases compared with controls (Romney et al.,
1981), one found a significant reduction in serum #-
carotene levels in a group of women with invasive
cancer (Orr et al., 1985), while the other two studies
showed no differences that were statistically
significant (Bernstein & Harris, 1984; Lambert et
al., 1985). This paper reports an examination of
retinol and P-carotene in serum samples remaining
from a previously published study (Harris et al.,
1980) based on women with dysplasia, carcinoma-
in-situ, and invasive cancer of the uterine cervix
and on an age-matched control group of women.
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Materials and methods
Women with invasive cancer of the cervix or with
pre-invasive disease and a control group of women
with various benign gynaecological problems were
interviewed between 1975 and 1979 at two hospitals
and a health centre in Oxfordshire. A sexual,
obstetric and contraceptive history was obtained
from each woman and blood samples were taken at
the time of interview from most of those who
participated in the study. In all cases of pre-
invasive disease, blood samples were taken prior to
any treatment, whilst most invasive cancer patients
were undergoing radiotherapy at the time of
sampling. Usually interviews were conducted in
hospital out-patient clinics. The blood was centri-
fuged and the serum stored at -40°C. The major
epidemiological aspects of this study have been
reported previously (Harris et al., 1980).
In total, serum samples from 113 cases,
comprising 43 women with dysplasia, 38 with
carcinoma-in-situ, and 32 with invasive cancer, and
from 226 control women (matched for 5-year age
group) were used in the present study.
Serum samples were assayed for retinol and ,B-
carotene in the laboratory of the Vitamin Division
of Hoffman-La Roche, Basle, Switzerland without
knowledge of whether samples were from case or
control women. Both substances were measured by
high-pressure liquid chromatography (Vuilleumier
et al., 1983). All the serum samples had been
thawed twice previously for other investigations, so
that any effect of light, thawing and re-freezing on
vitamin A levels would have been uniform
throughout.
Analysis was carried out between 6 and 9 years
after collection and initial freezing. The distribution
of the f-carotene concentrations was normalised by
log transformation. This was not necessary with the
retinol values as they were normally distributed
without transformation. It was also clear that, as
has been found by others (Wald et al., 1984;
Mathews-Roth & Stampfer, 1984), there was no loss
of retinol activity after freezing for this length of
time, but there was some decline in f-carotene
activity in the older samples. Accordingly each
fl-carotene determination was adjusted by the use of
a correction factor (al) multiplied by the number of
months the sample had been in storage (n). The
correction factor, was derived by least squares
fitting of the lines log(fl-carotene concentration)=
k+aln to the data for controls and log(fl-carotene
concentration)=k1+a1n+1 to those for cases. For
each data point the log concentration was corrected
by subtracting a1n which increases the concen-
tration as a1 is negative.
Relative risks were computed for quintiles of
serum levels of vitamin A and f-carotene as
determined by the distributions among the controls,
I being the lowest group and V the highest. The
odds ratio for each quintile was calculated by a
logistic regression model (Breslow & Day, 1980)
after stratifying by age in 5-year age groups, using
group V as the standard. In the analysis adjustment
was made for a number of potential confounding
factors. These were current smoking habits (YIN),
current oral contraceptive (OC) usage (YIN), social
class (I, II, III, and IV+V), and number of sexual
partners (0-1, 2-5, 6+). Each case group was
analysed independently in comparison with all the
control women.
Results
The mean serum retinol and corrected f-carotene
levels are shown in Table I for patients with each
stage of the disease and for all the control women.
The results are shown adjusted for age and also for
age together with the confounding factors referred
to above. The mean levels of serum retinol are very
similar in cases of all the disease categories and in
cases and controls after full adjustment. This is also
true for mean levels of serum P-carotene when
comparing invasive cancer cases with controls.
However for both of the pre-invasive disease
categories the levels of f-carotene are lower
amongst the cases than the controls, the difference
being significant (P<0.05) for the carcinoma-in-situ
category and for both the pre-invasive categories
combined after full adjustment.
Table II shows the number of patients in each
disease group with serum levels of retinol and
fl-carotene corresponding to the quintiles of the
control population. The corresponding odds ratios,
after age stratification and adjustment for the effects
of smoking, number of sexual partners, social class,
and current OC use, are shown in Table III for
retinol and in Table IV for fl-carotene.
No significant elevations, reductions, or trends in
the odds ratios were found with retinol or f-
carotene in any disease group. In the carcinoma-in-
situ group, the odds ratio was greater than 4 in the
three lowest #-carotene quintiles and of borderline
significance (level I, P=0.060; level II, P=0.087;
level III, P=0.062). The comparison of the lowest
four quintiles for the carcinoma-in-situ group with
the highest gives an odds ratio of 4.0 which is also
of borderline significance (P=0.081). When the two
pre-invasive disease categories are combined an
elevated odds ratio, again of borderline significance,
is found for two of the three lower quintiles and for
the four low quintiles combined (level I, P=0.049,
level III, P=0.021, levels I-IV, P=0.061). Tests forCANCER OF THE CERVIX UTERI AND VITAMIN A 655
Table I Serum retinol and corrected fl-carotene concentrations in control women and cases, by
stage of disease of the cervix uteri.
Figures are arithmetic means (pgl-') for retinol and geometric means (jgl-) for fl-carotene after
age adjustment and shown with and without additional adjustment for current smoking, current
OC usage, number of sexual partners, and social class.
Retinol fl-carotene
Age Fully Age Fully
N adjusted1 adjusted2 adjusted' adjusted2
Severe dysplasia 43 589.1 551.4 208.8a 228.7
Carcinoma-in-situ 38 563.7 532.0 205.Oa 213.la
All pre-invasive disease 81 577.3 542.3 2070b 221.3a
Invasive cancer 32 554.3 543.1 303.1 293.6
Controls 226 550.4 550.4 291.6 291.6
aSignificantly different from control women, P<0.05;3 bSignificantly different from control women,
P<0.01.
'Age adjusted means calculated by analysis of covariance (Armitage, 1971). The coefficients ai and
bi are calculated after least squares fitting of the line:
11 3
Serum concentration=k+ aixi+ E biy
i=l i=l
xi = 1 when the subject is in the (i+ 1)th age stratum, else xi=0.
y, = 1 for case of severe dysplasia
Y2 = 1 for case of carcinoma in situ
Y3= 1 for case of invasive cancer
else yi=0.
The adjusted means are then computed by substituting the proportion of controls in each age
stratum for xi and setting yi=0 for the control means and yi=1 for the case means.
2Fully adjusted mean calculated as in (1) above but with extra terms in the model as follows:
x12 =current smoking (0=No, 1=Yes)
x 3 =current OC usage (0=No, 1=Yes)
x14=No. of sexual partners (1=0 or 1, 2=2-5, 3=6+)
x15 =Social class (1=1, 2=II, 3=111, 4=IV or V)
3Significance calculated from t-ratio (coefficient/standard deviation) for case-control terms in
multiple regression model.
Table II Quintiles used in analysis and number in each quintile.
Cases
Severe Carcinoma- Invasive
Quintile Controls dysplasia in-situ cancer Total
Retinol (jg1-)
I 0-428 43 4 8 4 16
II 429-501 46 9 9 9 27
III 502-563 45 6 4 4 14
IV 564-654 47 13 10 9 32
V (reference) 655+ 45 11 7 6 24
All 226 43 38 32 113
,B-carotene (pgl-1)
I 0-150 45 12 9 4 25
II 151-245 47 8 11 9 28
III 246-385 46 13 12 7 32
IV 386-620 44 6 4 6 16
V (reference) 620+ 44 4 2 6 12
All 226 43 38 32 113
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Table III Odds ratio calculations for quintile groups of serum retinol for different stages
of cervical cancer (95% confidence intervals), after age stratification and adjustment for
number of sexual partners, current smoking status, current usage of oral contraceptives,
and social class.
Severe Carcinoma-in- All
Quintile dysplasia situ pre-invasive Invasive cancer
I-IV 1.2 (0.5-2.8) 2.0 (0.7-5.8) 1.5 (0.7-3.1) 1.5 (0.5-4.6)
I 0.6 (0.2-2.3) 1.9 (0.5-7.0) 1.1 (0.4-3.0) 1.1 (0.2-5.3)
II 1.7 (0.5-5.3) 2.3 (0.6-8.4) 1.7 (0.7-4.5) 2.1 (0.5-8.3)
III 0.8 (0.2-2.7) 1.1 (0.3-4.9) 0.9 (0.3-2.6) 1.1 (0.2-4.9)
IV 1.7 (0.6-4.7) 2.3 (0.7-7.9) 2.1 (0.9-5.0) 1.5 (0.4-5.6)
V 1.0 1.0 1.0 1.0
Table IV Odds ratio calculations for quintile groups of serum fl-carotene for different
stages of cervical cancer (95% confidence intervals), after age stratification and adjustment
for number of sexual partners, current smoking status, current usage of oral
contraceptives, and social class.
Severe Carcinoma-in- All
Quintile dysplasia situ pre-invasive Invasive cancer
I-IV 2.3 (0.7-7.3) 4.0 (0.8-18.7) 2.6 (1.0-7.1 ) 1.3 (0.5-3.6)
I 2.7 (0.7-11.4) 5.3 (0.9-30.8) 3.4 (1.0-11.2) 1.1 (0.2-5.0)
II 1.6 (0.4-6.5) 4.4 (0.8-23.8) 2.3 (0.7-7.2) 1.4 (0.4-4.9)
III 3.1 (0.9-11.6) 4.9 (0.9-25.2) 3.7 (1.2-11.3) 1.7 (0.4-6.8)
IV 1.9 (0.4-7.8) 2.2 (0.3-13.6) 1.7 (0.5-5.8) 1.0 (0.3-3.7)
V 1.0 1.0 1.0 1.0
trend in the odds ratios in the quintile groups just
failed to reach statistical significance for the
carcinoma-in-situ and both pre-invasive disease
groups combined (P=0.052 and P=0.088, 2-sided,
respectively).
We have also used these data to investigate the
effects of smoking and oral contraceptive usage on
retinol and fl-carotene levels. The results of this
analysis are shown in Table V for the control
women only. Both smoking and OC usage are
independently associated with the serum measures,
both habits tending to be linked with relatively high
retinol and low f-carotene levels respectively. The
effect of smoking on fl-carotene is quite strong,
reducing the mean serum concentration by about
38%. These results were found to be similar in pre-
and postmenopausal women.
Discussion
Our findings do not support the idea that there is
any association between low levels of serum retinol
and an increased risk of cervical cancer. No
significant relationship was found between the
serum levels and any stage of disease. The findings
do, however, suggest that P-carotene might have a
weak inverse association with pre-invasive cancer
although not with invasive cancer.
It is possible that the data for women with
carcinoma-in-situ are the most informative, as
women with invasive cancer may have had dietary
and metabolic changes as a result of their disease
(Wald et al., 1986) while those with severe dysplasia
may not all progress to invasive disease even if
untreated. This was not, however, a prior
hypothesis and the results, based on only 38
carcinoma-in-situ cases with large 95% confidence
intervals, could be due to chance. The original
epidemiological study (Harris et al., 1980) was of
pre-invasive disease only and a specific effect on
such disease was postulated with the group of
patients with invasive cancer added for comparison.
It is, therefore, of interest that the results for pre-
invasive disease show that cases have 25% lower #-
carotene levels than controls and that not being in
the top quintile for serum fl-carotene appears to
increase the risk of pre-invasive disease by about 2.6
times. In addition the trend between lower serum fi-CANCER OF THE CERVIX UTERI AND VITAMIN A 657
Table V Age adjusteda serum retinol and corrected fl-carotene concentrations in control
women by current smoking and oral contraceptive use.
Figures are arithmetic means (jigl-P) for retinol and geometric means (jigl-P) for ,B-carotene.
Significance of
Non-current Current association with
smoker smoker All smoking
Non-current OC user
No. 112 54 166
Serum retinol 509.8 564.8 527.7 <0.05
Serum fl-carotene 367.3 229.6 314.2 <0.001
Current OC user
No. 37 23 60
Serum retinol 592.7 648.2 612.9 NS
Serum f-carotene 281.6 176.0 237.3 <0.5
All
No. 149 77 226
Serum retinol 530.7 588.3 550.4 <0.01
Serum f-carotene 343.0 213.1 291.6 <0.001
Significance of
association with OC use
Retinol <0.5 <0.05 <0.001
fl-carotene NS NS <0.05
aAdjusted by analysis of covariance as in footnote (1) Table I.
carotene and increased risk of pre-invasive disease
is of borderline significance.
Cervical cancer has been shown to be associated
with a number of risk factors, those relating to
sexual behaviour having by far the largest effect
(Harris et al., 1980; Singer, 1979). Low social class
(OPCS, 1982), smoking (Greenberg et al., 1985),
and possibly long-term oral contraceptive usage
(Harris et al., 1980; Peritz et al., 1977) are, however,
also positively associated with this disease. Within
this context of a multifactorial aetiology and taking
current knowledge of the effects of vitamin A and
related substances into account. it seems unlikely
that more than a weak inverse association between
vitamin intake and cancer incidence would be
found. Our results for pre-invasive cancer and ,B-
carotene are consistent with such a relationship, but
even a weak relationship, if causal, could indicate a
method of prophylaxis which would have a major
effect on cancer incidence rates (Peto, 1983).
Prophylaxis with f-carotene would moreover be
practicable as increased consumption is directly and
proportionally reflected in increased serum levels,
which is not true of retinol as the serum level is
homeostatically maintained more or less constant
and excessive consumption can be hepato-toxic. It
might therefore be profitable to investigate further
the speciflc association between fl-carotene and
carcinoma-in-situ.
One previous study has found an inverse
association between severe dysplasia and carcinoma
in situ and dietary consumption of foods rich in /3-
carotene (Romney, et al., 1981) while two have
found a similar relationship with invasive cancer
(Marshall et al., 1983; La Vecchia et al., 1984).
None of them have found any association with
retinol consumption. Of the three other serum
studies, the two concerned with pre-invasive disease
(Bernstein & Harris, 1984; Lambert et al., 1981)
showed no significant effects whereas the third (Orr
et al., 1985) showed that women with invasive
disease had lower fl-carotene, but not retinol, levels
than controls.
Our results are consistent with those of most
other studies which have looked at the influence of
smoking and oral contraceptive usage on serum
retinol and fl-carotene level. The tendency for
smoking to be associated with an increased retinol
and decreased fl-carotene level has been reported
previously (Yeung, 1976; Witter et al., 1982; Salonen
et al., 1985) although some data sets are not
consistent with such a relationship for retinol (Wald,
personal communication). A positive effect of OC
usage on retinol concentrations has also been found
previously Gal et al., 1971; Gal & Parkinson, 1973;
Yeung, 1974, 1976; Smith et al., 1975; Yeung &
Chan, 1975), but there is some controversy as to
whether it affects fl-carotene (Yeung & Chan, 1975).658 R.W.C. HARRIS et al.
The general conclusions from other studies - that
smoking is more effective than OC usage in
reducing f-carotene and less effective in increasing
retinol - are, however, confirmed by our results. It
is unclear whether the mode of action is the result
of a direct pharmacological effect (perhaps
catalysing the conversion of f-carotene to retinol or
stimulating the synthesis of retinol binding protein
and hence increasing serum concentration) or
whether smoking and OC usage tend to be
associated with dietary habits that lead to a
reduced f-carotene intake and increased retinol
circulation. The fact that serum vitamin A levels
fluctuate in a cyclical pattern throughout the
menstrual cycle (Yeung, 1974), and that this pattern
is disturbed by OC usage (Gal et al., 1971; Gal &
Parkinson, 1973; Yeung, 1974), would suggest a
direct, if complex, biochemical relationship between
hormonal and micronutrient components in the
serum. It is of course possible that both biochemical
effects and associated dietary changes accom-
panying OC usage and smoking are involved.
Since smoking and OC usage affect retinol and ,B-
carotene and our previous report (Harris et al.,
1980) also associated these variables with the risk of
precancerous lesions, they are both potential
confounding factors. Indeed it is possible that these
variables affect disease through the modification of
micronutrient levels. They were, therefore, both
taken into account in our analysis of odds ratios, as
were number of sexual partners and social class.
Number of sexual partners was a major risk factor
in our previous analysis and although social class
was not a risk factor in this study it has been
reported as such in many other investigations
(OPCS, 1982). Neither of these factors affected
retinol levels in our control series but there was a
relationship between social class and fl-carotene
concentration, which was higher in women in the
upper social class groups.
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